This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Phosphatidylinositol-binding clathrin assembly protein.
Involved in AP2-dependent clathrin-mediated endocytosis at the neuromuscular junction. .
Human | |
---|---|
Gene Name: | PICALM |
Uniprot: | Q13492 |
Entrez: | 8301 |
Belongs to: |
---|
PICALM/SNAP91 family |
CALMclathrin assembly lymphoid-myeloid leukemia; Clathrin assembly lymphoid myeloid leukemia protein; CLTHphosphatidylinositol-binding clathrin assembly protein; LAP; phosphatidylinositol binding clathrin assembly protein
Mass (kDA):
70.755 kDA
Human | |
---|---|
Location: | 11q14.2 |
Sequence: | 11; NC_000011.10 (85957175..86069860, complement) |
Expressed in all tissues examined.
Cell membrane. Membrane, clathrin-coated pit. Golgi apparatus. Cytoplasmic vesicle, clathrin-coated vesicle. Nucleus. Colocalized with clathrin in the Golgi area (PubMed:10436022). Interaction with PIMREG may target PICALM to the nucleus in some cells (PubMed:16491119).
If you are looking for an informative bio, you should read this article. It will provide you with an overview of Steven Boster's history, current projects, and products. Steven Boster is a well-known biotechnology inventor. His unique approach to the development of biotechnology products has helped many medical professionals in a variety of fields. His work has led to a number of patents and a number of patented technologies.
If you are interested in pursuing a Ph.D. in Biomedical Science, you should consider applying for a Boster Bio Scholarship. A Boster Bio scholarship is a one-time award given to an undergraduate student who has shown academic promise in his or her field of study. This award will help fund research that will improve the lives of people in need. The Boster Bio scholarship is awarded to students who have exceptional research potential and can demonstrate evidence of their ability to translate their research into practical applications.
There are numerous opportunities for PICALM to influence the pathogenesis of AD. A prominent hypothesis holds that PICALM regulates the internalization of APP and production of Ab. Additionally, PICALM may act through its role in endocytosis and trafficking. This is a promising line of research. More studies are needed to understand how this protein influences the pathogenesis of AD. To date, researchers have been able to identify PICALM-mediated processes that affect APP internalization and Ab production.
Because PICALM is not present in the perinuclear region, it is not known whether it directly influences clathrin targeting. However, it likely has a role in regulating trafficking between early endosomes and the transgolgi network. As there are several proteins involved in this process, depletion of PICALM may affect multiple targets. Moreover, PICALM is involved in the endocytosis of R-SNAREs, which are soluble NSF attachment protein receptors that are essential for their fusion with endosomes and the plasma membrane.
In 1993, Steven Boster developed his first product. He later earned the nickname "he who converts science in the lavatory," and went on to develop hundreds of primary antibodies. He became the largest catalog antibody company in China by the late 1990s. Boster is a world leader in antibody research and development, and its most notable invention is a proprietary ELISA platform, PicoKine(tm). This platform uses proprietary trade secrets to deliver high-sensitivity ELISA kits to researchers.
Boster Bio is a renowned manufacturer of antibodies, ELISA kits, and other products used in molecular biology research. This company has over 14000 product citations and 20 years of experience. They make their antibodies in-house and test them using real tissues and known amounts of recombinant proteins. Their ELISA kits are used by researchers worldwide to monitor and measure protein levels in various diseases. They also offer a guarantee on all of their products, giving scientists peace of mind.
Boster Bio also offers multiplex immunohistochemistry services, allowing researchers to identify a wide variety of targets simultaneously. The company's Multiplex Immunohistochemistry services enable rapid assay processing and high throughput during screening. With over 16,000 validated antibodies, Boster Bio can help you find the exact antibodies you need, quickly. And thanks to their high-throughput screening method, they can process the highest volumes of cells in record time.
The Boster Bio team is devoted to producing high-quality antibodies for ELISA and WB applications. Their products have been rigorously validated, and they've received over two thousand citations. In addition to producing high-quality antibodies, Boster also offers multiplex IHC services and archives results in record time. Their antibody selection is comprehensive and covers a variety of applications from neuroscience to biotechnology. And all Boster Bio products are backed by a 100% satisfaction guarantee.
PMID: 8643484 by Dreyling M.H., et al. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.
PMID: 9737689 by Silliman C.C., et al. Alternative splicing in wild-type AF10 and CALM cDNAs and in AF10- CALM and CALM-AF10 fusion cDNAs produced by the t(10;11)(p13-14;q14- q21) suggests a potential role for truncated AF10 polypeptides.